We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RETA
876
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$354K ﹤0.01%
1,735
+1,266
+270% +$231K
NHI icon
877
National Health Investors
NHI
$3.85B
$350K ﹤0.01%
4,300
LSXMK
878
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$347K ﹤0.01%
9,477
LPSN icon
879
LivePerson
LPSN
$22.4M
$344K ﹤0.01%
621
+48
+8% +$27.6K
ERIC icon
880
Ericsson
ERIC
$32.7B
$343K ﹤0.01%
39,168
+23
+0.1% +$204
XHB icon
881
State Street SPDR S&P Homebuilders ETF
XHB
$1.69B
$342K ﹤0.01%
7,533
PWB icon
882
Invesco Large Cap Growth ETF
PWB
$2.23B
$341K ﹤0.01%
6,642
VRSN icon
883
VeriSign
VRSN
$25.6B
$341K ﹤0.01%
1,775
+390
+28% +$73.3K
KEX icon
884
Kirby Corp
KEX
$7.63B
$338K ﹤0.01%
3,777
EVBG
885
DELISTED
Everbridge, Inc. Common Stock
EVBG
$333K ﹤0.01%
4,269
+194
+5% +$15K
WHD icon
886
Cactus
WHD
$3.67B
$329K ﹤0.01%
9,593
+428
+5% +$13K
ATR icon
887
AptarGroup
ATR
$8.75B
$328K ﹤0.01%
2,843
-1,404
-33% -$160K
MRO
888
DELISTED
Marathon Oil Corporation
MRO
$328K ﹤0.01%
24,270
-3,314
-12% -$40.4K
TFSL icon
889
TFS Financial
TFSL
$5.16B
$324K ﹤0.01%
16,509
+74
+0.5% +$1.43K
CTXS
890
DELISTED
Citrix Systems Inc
CTXS
$324K ﹤0.01%
2,927
-26
-0.9% -$2.8K
KDP icon
891
Keurig Dr Pepper
KDP
$42.1B
$322K ﹤0.01%
11,139
-57
-0.5% -$1.64K
MOG.A icon
892
Moog Inc Class A
MOG.A
$13.2B
$322K ﹤0.01%
3,774
+78
+2% +$6.67K
BUD icon
893
AB InBev
BUD
$161B
$318K ﹤0.01%
3,894
-30,261
-89% -$2.52M
GMED icon
894
Globus Medical
GMED
$10.8B
$318K ﹤0.01%
5,406
+153
+3% +$8.31K
NBTB icon
895
NBT Bancorp
NBTB
$2.78B
$318K ﹤0.01%
7,898
+26
+0.3% +$1.02K
NGG icon
896
National Grid
NGG
$81.7B
$318K ﹤0.01%
5,751
-32,642
-85% -$1.68M
AV
897
DELISTED
Aviva Plc
AV
$317K ﹤0.01%
28,742
+507
+2% +$5.59K
LULU icon
898
lululemon athletica
LULU
$13.6B
$316K ﹤0.01%
1,366
-8
-0.6% -$1.71K
HRC
899
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$316K ﹤0.01%
2,791
+84
+3% +$8.85K
MORN icon
900
Morningstar
MORN
$7.37B
$315K ﹤0.01%
2,085
-158
-7% -$24.3K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.